Published on : May 17, 2017
Albany, New York, May 17, 2017: Tetanus is a frightening disease that has plagued mankind since ancient times. Market Research Hub (MRH) has recently broadcasted a pipeline study done on this bacterial disease and titled as “Tetanus - Pipeline Review, H1 2017”. This study examines comprehensive information on the therapeutics under development for Tetanus (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Moreover, its pipeline analysis by companies involved in its therapeutic development is also mentioned in detail.
Tetanus, commonly called lockjaw, is a bacterial disease caused by Clostridium bacteria which affects the nervous system. It is contracted through a cut or wound that becomes tainted with tetanus bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles, difficulty swallowing, the stiffness of abdominal muscles, fever, sweating, elevated blood pressure and rapid heart rate. Unlike many other diseases, tetanus is not commonly diagnosed through laboratory tests. Those infected with this disease will be given medication or vaccines to fight off the bacteria. Treatment includes antibiotics, beta blockers and sedatives.
The report initiates with the overview of Tetanus and its therapeutic assessment. Further, the pipeline overview, pipeline companies, and products under development by companies are detailed. As per the report findings, Clostridium tetani is widespread in the environment throughout the world and cannot be eradicated. To reduce the number of cases of tetanus efforts are focused on prevention using vaccination and post-exposure wound care. Vaccination is the finest way to protect against tetanus infection. Due to widespread immunization, tetanus is a rare disease in the U.S. There are four kinds of vaccines used to protect against tetanus, such as Diphtheria and Tetanus (DT) Vaccines; Diphtheria, tetanus and pertussis (DTaP) vaccines; Tetanus and diphtheria (Td) vaccines; Tetanus, diphtheria and pertussis (Tdap) vaccines.
Moreover, the pipeline guide reviews key companies involved in Tetanus (Infectious Disease) therapeutics and enlists all their major and minor projects. They are as follows Beijing Minhai Biotechnology Co. Ltd., Daiichi Sankyo Company Ltd., Panacea Biotec Ltd., Serum Institute of India Ltd., GlaxoSmithKline Plc, Bharat Biotech International Ltd., Indian Immunologicals Ltd., Prometheon Pharma LLC, Shantha Biotechnics Ltd., Zydus Cadila Healthcare Ltd., Biological E Ltd., Kaketsuken KK, Boryung Pharmaceutical Co. Ltd., Green Cross Corp., LG Chem, Ltd. and Sanofi Pasteur SA.
In the later part, the pipeline analysis also features drug profiles for the pipeline products which covers, product descriptive licensing and alliance details, R&D brief and other developmental activities.
Click here to get more info with TOC in a PDF Format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1068027
The pipeline guide reviews the latest news and press releases related to pipeline therapeutics for Tetanus. Hence, the present guide is a complete repository of information, built using data and information sourced from registered databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org